Left main revascularization with PCI or CABG in patients with chronic kidney disease: EXCEL trial

G Giustino, R Mehran, PW Serruys, JF Sabik… - Journal of the American …, 2018 - jacc.org
Background: The optimal revascularization strategy for patients with left main coronary artery
disease (LMCAD) and chronic kidney disease (CKD) remains unclear. Objectives: This …

Mortality after repeat revascularization following PCI or CABG for left main disease: the EXCEL trial

G Giustino, PW Serruys, JF Sabik III, R Mehran… - Cardiovascular …, 2020 - jacc.org
Objectives The aim of this study was to investigate the incidence and impact on mortality of
repeat revascularization after index percutaneous coronary intervention (PCI) or coronary …

Revascularization in patients with left main coronary artery disease and left ventricular dysfunction

S Park, JM Ahn, TO Kim, H Park, DY Kang… - Journal of the American …, 2020 - jacc.org
Background Left main coronary artery (LMCA) disease is associated with high mortality and
morbidity due to a large area of jeopardized myocardium. However, the optimal …

Percutaneous coronary intervention or coronary artery bypass graft surgery for left main coronary artery disease: a meta-analysis of randomized trials

T Kuno, H Ueyama, SV Rao, MG Cohen… - American Heart …, 2020 - Elsevier
We aimed to investigate long-term (≥ 5 years) outcomes of percutaneous coronary
intervention (PCI) versus coronary artery bypass grafting (CABG) for left main coronary …

Meta-analysis of percutaneous coronary intervention versus coronary artery bypass grafting in left main coronary artery disease

AR Khan, H Golwala, A Tripathi, H Riaz… - The American journal of …, 2017 - Elsevier
Despite the increase in use of percutaneous coronary intervention (PCI) in left main
coronary disease, its efficacy compared with coronary artery bypass grafting (CABG) is …

Percutaneous coronary intervention versus coronary artery bypass grafting in patients with end-stage renal disease requiring dialysis (5-year outcomes of the CREDO …

A Marui, T Kimura, N Nishiwaki, K Mitsudo… - The American journal of …, 2014 - Elsevier
Ischemic heart disease is a major risk factor for morbidity and mortality in patients with end-
stage renal disease. However, long-term benefits of percutaneous coronary intervention …

Survival after coronary revascularization among patients with kidney disease

BR Hemmelgarn, D Southern, BF Culleton… - Circulation, 2004 - Am Heart Assoc
Background—The optimal approach to revascularization in patients with kidney disease has
not been determined. We studied survival by treatment group (CABG, percutaneous …

[HTML][HTML] Percutaneous intervention versus coronary artery bypass graft surgery in left main coronary artery stenosis: a systematic review and meta-analysis

XL Zhang, QQ Zhu, JJ Yang, YH Chen, Y Li, SH Zhu… - Bmc Medicine, 2017 - Springer
Background The optimal revascularization technique in patients with left main coronary
artery disease (CAD) remains controversial. We aimed to compare the long-term …

Percutaneous coronary intervention versus coronary artery bypass graft surgery in left main coronary artery disease: a meta-analysis of randomized clinical data

D Capodanno, GW Stone, MC Morice, TA Bass… - Journal of the American …, 2011 - jacc.org
Objectives: The purpose of this study was to determine the safety and efficacy of
percutaneous coronary intervention (PCI) compared with coronary artery bypass graft …

Bypass surgery or stenting for left main coronary artery disease in patients with diabetes

M Milojevic, PW Serruys, JF Sabik, DE Kandzari… - Journal of the American …, 2019 - jacc.org
Abstract Background: The randomized EXCEL (Evaluation of XIENCE versus Coronary
Artery Bypass Surgery for Effectiveness of Left Main Revascularization) trial reported a …